Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Mã chứng khoánRDY
Tên công tyDr Reddy's Laboratories Ltd
Ngày IPOJan 01, 1986
Giám đốc điều hànhAghanian (Patrick)
Số lượng nhân viên27811
Loại chứng khoánDepository Receipt
Kết thúc năm tài chínhJan 01
Địa chỉ8-2-337, Road No.3 Banjara Hills
Thành phốHYDERABAD
Sàn giao dịch chứng khoánNASDAQ OMX NASDAQ Basic NYSE
Quốc giaIndia
Mã bưu điện500-034
Điện thoại914049002900
Trang webhttps://www.drreddys.com/
Mã chứng khoánRDY
Ngày IPOJan 01, 1986
Giám đốc điều hànhAghanian (Patrick)